Featured
-
-
Article |
Tumor-associated neutrophils suppress CD8+ T cell immunity in urothelial bladder carcinoma through the COX-2/PGE2/IDO1 Axis
- Yi Ouyang
- , Wenlong Zhong
- & Tianxin Lin
-
Article
| Open AccessIntegrative score based on CDK6, PD-L1 and TMB predicts response to platinum-based chemotherapy and PD-1/PD-L1 blockade in muscle-invasive bladder cancer
- Xiaohe Su
- , Kaifeng Jin
- & Jiejie Xu
-
Review Article
| Open AccessSystemic anticancer therapy for urothelial carcinoma: UK oncologists’ perspective
- Robert J. Jones
- , Simon J. Crabb
- & Syed A. Hussain
-
Article
| Open AccessUrine-derived bladder cancer organoids (urinoids) as a tool for cancer longitudinal response monitoring and therapy adaptation
- Bastiaan J. Viergever
- , Daniëlle A. E. Raats
- & Richard P. Meijer
-
Article |
Phase II trial of afatinib in patients with advanced urothelial carcinoma with genetic alterations in ERBB1-3 (LUX-Bladder 1)
- Albert Font
- , Begona Mellado
- & Francisco X. Real
-
Article
| Open AccessExposure to low-level ambient air pollution and the relationship with lung and bladder cancer in older men, in Perth, Western Australia
- Elizabeth H. Lim
- , Peter Franklin
- & Jane Heyworth
-
Article |
A clinically practical model for the preoperative prediction of lymph node metastasis in bladder cancer: a multicohort study
- Junlin Lu
- , Jiajian Lai
- & Tianxin Lin
-
Article
| Open AccessExposure to benzene and other hydrocarbons and risk of bladder cancer among male offshore petroleum workers
- Nita K. Shala
- , Jo S. Stenehjem
- & Tom K. Grimsrud
-
-
Article
| Open AccessSelective inhibition of HDAC6 promotes bladder cancer radiosensitization and mitigates the radiation-induced CXCL1 signalling
- Yu-Chieh Tsai
- , Tzu-Yin Wang
- & Sheng-Fang Su
-
Article |
Downregulation of CBX7 induced by EZH2 upregulates FGFR3 expression to reduce sensitivity to cisplatin in bladder cancer
- Jiannan Ren
- , Haixin Yu
- & Bin Yan
-
Article |
Multicentric validation of diagnostic tests based on BC-116 and BC-106 urine peptide biomarkers for bladder cancer in two prospective cohorts of patients
- Lourdes Mengual
- , Maria Frantzi
- & Antoine G. Van der Heijden
-
Article
| Open AccessIntegrative tumour mutation burden with CD39 and PD-L1 for the prediction of response to PD-L1 blockade and adjuvant chemotherapy in muscle-invasive bladder cancer patients
- Chunnan Liu
- , Zhaopei Liu
- & Weijuan Zhang
-
Article |
EphA2 on urinary extracellular vesicles as a novel biomarker for bladder cancer diagnosis and its effect on the invasiveness of bladder cancer
- Eisuke Tomiyama
- , Kazutoshi Fujita
- & Norio Nonomura
-
Article |
SBSN drives bladder cancer metastasis via EGFR/SRC/STAT3 signalling
- Zhongqiu Zhou
- , Zhuojun Zhang
- & Lili Jiang
-
Article |
Non-muscle-invasive micropapillary bladder cancer has a distinct lncRNA profile associated with unfavorable prognosis
- Joep J. de Jong
- , Begoña P. Valderrama
- & Joaquim Bellmunt
-
Article
| Open AccessInvestigation of urinary volatile organic compounds as novel diagnostic and surveillance biomarkers of bladder cancer
- Lauren Lett
- , Michael George
- & Chris Probert
-
Article |
Vegetable and fruit intake and the risk of bladder cancer: Japan Public Health Center-based prospective study
- Nobuhiro Narii
- , Tomotaka Sobue
- & Shoichiro Tsugane
-
Article |
Long-term exposure to ambient air pollution and bladder cancer incidence in a pooled European cohort: the ELAPSE project
- Jie Chen
- , Sophia Rodopoulou
- & Gerard Hoek
-
Article |
CD103+CD8+ tissue-resident memory T cell infiltration predicts clinical outcome and adjuvant therapeutic benefit in muscle-invasive bladder cancer
- Kaifeng Jin
- , Yanze Yu
- & Zewei Wang
-
Article |
TIGIT and PD-1 expression atlas predicts response to adjuvant chemotherapy and PD-L1 blockade in muscle-invasive bladder cancer
- Zhaopei Liu
- , Han Zeng
- & Zewei Wang
-
Article |
Pretreatment tumour immune microenvironment predicts clinical response and prognosis of muscle-invasive bladder cancer in the neoadjuvant chemotherapy setting
- Daiki Ikarashi
- , Shigehisa Kitano
- & Wataru Obara
-
Article
| Open AccessTenascin-C expression in the lymph node pre-metastatic niche in muscle-invasive bladder cancer
- Christopher R. Silvers
- , Edward M. Messing
- & Yi-Fen Lee
-
Article |
Fibroblast growth factor receptor 3 alterations and response to immune checkpoint inhibition in metastatic urothelial cancer: a real world experience
- Tracy L. Rose
- , William H. Weir
- & William Y. Kim
-
Article
| Open AccessA miRNA signature predicts benefit from addition of hypoxia-modifying therapy to radiation treatment in invasive bladder cancer
- Mairah T. Khan
- , Joely J. Irlam-Jones
- & Catharine M. L. West
-
Article
| Open AccessUrological cancer patients receiving treatment during COVID-19: a single-centre perspective
- Sophie Therese Williams
- , Salma El Badri
- & Syed Anwer Hussain
-
Article
| Open AccessNatural history, response to systemic therapy, and genomic landscape of plasmacytoid urothelial carcinoma
- Min Yuen Teo
- , Hikmat Al-Ahmadie
- & Jonathan E. Rosenberg
-
Editorial |
Predicting immune checkpoint inhibitor response in urothelial carcinoma: another step in personalised medicine?
- Günter Niegisch
-
Article
| Open AccessA model combining clinical and genomic factors to predict response to PD-1/PD-L1 blockade in advanced urothelial carcinoma
- Amin H. Nassar
- , Kent W. Mouw
- & David J. Kwiatkowski
-
Article
| Open AccessSystematic chemical screening identifies disulfiram as a repurposed drug that enhances sensitivity to cisplatin in bladder cancer: a summary of preclinical studies
- Yuki Kita
- , Akihiro Hamada
- & Takashi Kobayashi
-
Article
| Open AccessTYRO3 as a molecular target for growth inhibition and apoptosis induction in bladder cancer
- Florent Dufour
- , Linda Silina
- & Isabelle Bernard-Pierrot
-
Article
| Open AccessLoss of GAS5 tumour suppressor lncRNA: an independent molecular cancer biomarker for short-term relapse and progression in bladder cancer patients
- Margaritis Avgeris
- , Anastasia Tsilimantou
- & Andreas Scorilas
-
Article
| Open AccessCD24 regulates cancer stem cell (CSC)-like traits and a panel of CSC-related molecules serves as a non-invasive urinary biomarker for the detection of bladder cancer
- Akira Ooki
- , Christopher J. VandenBussche
- & Mohammad Obaidul Hoque
-
Article
| Open AccessPhase II trial of palbociclib in patients with metastatic urothelial cancer after failure of first-line chemotherapy
- Tracy L. Rose
- , David D. Chism
- & Matthew I. Milowsky
-
Article
| Open AccessRIPK4 promotes bladder urothelial carcinoma cell aggressiveness by upregulating VEGF-A through the NF-κB pathway
- Jian-Ye Liu
- , Qing-Hai Zeng
- & Ke Cao
-
Article
| Open AccessApatorsen plus docetaxel versus docetaxel alone in platinum-resistant metastatic urothelial carcinoma (Borealis-2)
- Jonathan E. Rosenberg
- , Noah M. Hahn
- & Toni K. Choueiri
-
Article
| Open AccessHealth-related quality of life after treatment for bladder cancer in England
- Samantha J Mason
- , Amy Downing
- & Adam W Glaser
-
Article
| Open AccessMapping of the three-dimensional lymphatic microvasculature in bladder tumours using light-sheet microscopy
- Nobuyuki Tanaka
- , Dagmara Kaczynska
- & Per Uhlén
-
Translational Therapeutics
| Open AccessProstaglandin receptors induce urothelial tumourigenesis as well as bladder cancer progression and cisplatin resistance presumably via modulating PTEN expression
- Eiji Kashiwagi
- , Satoshi Inoue
- & Hiroshi Miyamoto
-
Translational Therapeutics
| Open AccessHyaluronic acid family in bladder cancer: potential prognostic biomarkers and therapeutic targets
- Daley S Morera
- , Martin S Hennig
- & Vinata B Lokeshwar
-
Epidemiology
| Open AccessSmoking cessation and survival in lung, upper aero-digestive tract and bladder cancer: cohort study
- C Koshiaris
- , P Aveyard
- & A Farley
-
Genetics and Genomics
| Open AccessNon-invasive prediction of recurrence in bladder cancer by detecting somatic TERT promoter mutations in urine
- Françoise Descotes
- , Norelyakin Kara
- & Alain Ruffion
-
Molecular Diagnostics
| Open AccessRegulation of ITGA3 by the dual-stranded microRNA-199 family as a potential prognostic marker in bladder cancer
- Takashi Sakaguchi
- , Hirofumi Yoshino
- & Hideki Enokida
-
Molecular Diagnostics
| Open AccessThe predictive and prognostic value of tumour necrosis in muscle invasive bladder cancer patients receiving radiotherapy with or without chemotherapy in the BC2001 trial (CRUK/01/004)
- Ananya Choudhury
- , Catharine M West
- & Nicholas James
-
Molecular Diagnostics
| Open AccessIncreased micronucleus frequency in peripheral blood lymphocytes predicts the risk of bladder cancer
- Barbara Pardini
- , Clara Viberti
- & Giuseppe Matullo
-
Clinical Study
| Open AccessFast-track access to urologic care for patients with macroscopic haematuria is efficient and cost-effective: results from a prospective intervention study
- Fredrik Liedberg
- , Ulf Gerdtham
- & Mef Nilbert
-
Clinical Study
| Open AccessGenome-wide measures of DNA methylation in peripheral blood and the risk of urothelial cell carcinoma: a prospective nested case–control study
- Pierre-Antoine Dugué
- , Maree T Brinkman
- & Graham G Giles
-
Molecular Diagnostics
| Open AccessExpression of miR-210 in relation to other measures of hypoxia and prediction of benefit from hypoxia modification in patients with bladder cancer
- J J Irlam-Jones
- , A Eustace
- & C M L West
-
Clinical Study
| Open AccessAssociation of tumour microRNA profiling with outcomes in patients with advanced urothelial carcinoma receiving first-line platinum-based chemotherapy
- Joaquim Bellmunt
- , Chensheng Willa Zhou
- & Michaela Bowden